Dallas, TX (PRWEB) October 11, 2012
Primcogent Solutions, a global company with offices in Dallas, London, Munich, and New York, presented their diverse product line and unique business platform at the 14th Rodman and Renshaw Annual Healthcare Conference in New York last month.
Ryan Maloney, Vice President of Clinical Development, presented Primcogent Solutions’ unique and diverse product line, which includes three non-invasive low-level lasers. One device is the ZERONA laser, a non-invasive, safe and effective device for the circumferential reduction of the hips, waist, and thighs, which was FDA cleared in late 2010. Another device, Zerona AD, received an industry-first FDA clearance for the circumferential reduction of the upper arms in the summer of 2012. Finally, Lunula Laser is CE Marked for sale and distribution in Europe for the safe and effective treatment of toenail fungus. All three medical devices are manufactured by Erchonia, with each administering a non-invasive treatment with zero surgery, pain, recovery time, or side effects.
Primcogent Solutions is dedicated to offering healthcare products to the medical community backed by a clear, logical, and convincing scientific and clinical foundation. These unique non-invasive products provide a viable alternative to traditional medical products, and the unique rental model helps enhance practice profitability by eliminating the risks associated with purchasing equipment.
"I was extremely privileged to be able to speak at this conference,” said Ryan Maloney, Vice President of Clinical Development for Primcogent Solutions. “The Rodman and Renshaw Annual Healthcare Conference was an excellent avenue to help educate members of the healthcare community on the non-invasive techniques we have in the market, as well as our unique business model, two components that clearly differentiate our products and services from others.”
About Primcogent Solutions
Primcogent Solutions is dedicated to offering healthcare products to the medical community backed by a clear, logical, and convincing scientific and clinical foundation. Primcogent Solutions’ signature product ZERONA, manufactured by Erchonia Medical, is the only platform that is FDA cleared for the safe and effective simultaneous reduction of fat from the hips, waist and thighs. Primcogent Solutions’ revolutionary non-invasive body contouring technology, along with its unique physician business model, enhances practice profitability by eliminating the risks associated with purchasing capital equipment. For more information, visit http://www.primcogent.com.
Erchonia is the global leader in low-level laser healthcare applications. Over the last 15 years Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low-level lasers. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently, thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit http://www.erchonia.com.